
Olaparib shows promise in neoadjuvant ovarian cancer treatment.


coremsg

Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.

New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting

new-role-for-olaparib-in-brca-ovarian-cancer-in-neoadjuvant-setting


New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting
